American Shared Hospital Services(AMS)Earnings, Financials & Key Ratios
AMS•AMEX
$1.81
$12M mkt cap·5.5× P/E·Price updated May 6, 2026
AboutAmerican Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America in Lima, Peru and Guayaquil, Ecuador. The company also operates one PBRT system. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.Show more
- Revenue$28M+32.9%
- EBITDA$3M-38.0%
- Net Income$2M+258.4%
- EPS (Diluted)0.33+245.9%
- Gross Margin32.41%-26.0%
- EBITDA Margin11.89%-53.4%
- Operating Margin-9.9%-881.7%
- Net Margin7.71%+169.7%
- ROE7.76%+230.3%
- ROIC-5.81%-929.3%
- Debt/Equity0.77+15.2%
- Interest Coverage-1.87-870.7%
AMS Key Insights
American Shared Hospital Services (AMS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 27.1%
- ✓Trading at only 0.4x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 17 (bottom 17%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AMS Price & Volume
American Shared Hospital Services (AMS) stock price & volume — 10-year historical chart
Loading chart...
AMS Growth Metrics
American Shared Hospital Services (AMS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.28%
5 Years6.58%
3 Years17.15%
TTM17.84%
Profit CAGR
10 Years-
5 Years27.1%
3 Years124.19%
TTM-157.27%
EPS CAGR
10 Years-
5 Years6.58%
3 Years117.66%
TTM-164.3%
Return on Capital
10 Years-1.06%
5 Years-4.07%
3 Years0.16%
Last Year-6.44%
AMS Peer Comparison
American Shared Hospital Services (AMS) competitors in Healthcare staffing and facility services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ARAY | 58.45M | 0.49 | -31.75 | 2.68% | -10.76% | -77.48% | 2.17 | |
 NNOX | 117.04M | 1.79 | -1.97 | 13.91% | -452.82% | -35.55% | 0.04 | |
 BLCO | 5.7B | 16.00 | -15.69 | 6.47% | -4.21% | -3.37% | 0.82 | |
 IART | 1.09B | 14.00 | -2.08 | 1.53% | -30.15% | -47.65% | 1.95 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 GKOS | 7.92B | 135.27 | -41.24 | 32.33% | -34.34% | -26.46% | 0.21 | |
 EW | 47.97B | 83.20 | 45.46 | 11.55% | 17.64% | 10.35% | 0.07 | |
 HAE | 2.45B | 52.64 | 15.90 | 3.95% | 13.31% | 20.26% | 1.49 |
Compare AMS vs Peers
American Shared Hospital Services (AMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMS Income Statement
American Shared Hospital Services (AMS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 18.7M | 19.56M | 19.71M | 20.61M | 17.84M | 17.63M | 19.75M | 21.32M | 28.34M | 29.42M |
| Revenue Growth % | 13% | 4.58% | 0.81% | 4.52% | -13.43% | -1.17% | 12.02% | 8% | 32.9% | 17.84% |
| Cost of Goods Sold | 9.9M | 10.89M | 12.23M | 13.69M | 13.37M | 10.9M | 11.36M | 11.98M | 19.16M | 22.07M |
| COGS % of Revenue | 52.97% | 55.7% | 62.03% | 66.42% | 74.96% | 61.84% | 57.55% | 56.18% | 67.59% | - |
| Gross Profit | 8.79M▲ 0% | 8.66M▼ 1.5% | 7.49M▼ 13.6% | 6.92M▼ 7.6% | 4.47M▼ 35.5% | 6.73M▲ 50.6% | 8.38M▲ 24.6% | 9.34M▲ 11.5% | 9.19M▼ 1.7% | 7.35M▲ 0% |
| Gross Margin % | 47.03% | 44.3% | 37.97% | 33.58% | 25.04% | 38.16% | 42.45% | 43.82% | 32.41% | 24.98% |
| Gross Profit Growth % | 30.98% | -1.5% | -13.59% | -7.56% | -35.46% | 50.6% | 24.62% | 11.48% | -1.7% | - |
| Operating Expenses | 3.8M | 4.32M | 3.99M | 4.06M | 13.93M | 5.38M | 5.95M | 9.07M | 11.99M | 10.97M |
| OpEx % of Revenue | 20.33% | 22.11% | 20.26% | 19.7% | 78.09% | 30.49% | 30.14% | 42.55% | 42.31% | - |
| Selling, General & Admin | 3.8M | 4.32M | 3.99M | 4.06M | 4.61M | 4.53M | 5.14M | 7.02M | 7.41M | 6.79M |
| SG&A % of Revenue | 20.33% | 22.11% | 20.26% | 19.7% | 25.83% | 25.7% | 26.06% | 32.93% | 26.14% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 15K | 3K | 0 | 0 | 9.32M | 844K | 806K | 2.05M | 4.58M | 1.86M |
| Operating Income | 3.29M▲ 0% | 2.41M▼ 26.6% | 1.86M▼ 22.9% | -4.54M▼ 343.7% | -9.46M▼ 108.7% | 1.35M▲ 114.3% | 2.43M▲ 79.9% | 270K▼ 88.9% | -2.81M▼ 1138.9% | -3.63M▲ 0% |
| Operating Margin % | 17.57% | 12.34% | 9.44% | -22.01% | -53.05% | 7.66% | 12.31% | 1.27% | -9.9% | -12.32% |
| Operating Income Growth % | 65.96% | -26.57% | -22.88% | -343.69% | -108.67% | 114.28% | 79.94% | -88.89% | -1138.89% | - |
| EBITDA | 9.61M | 9.09M | 8.68M | 2.88M | -2.49M | 6.63M | 7.55M | 5.43M | 3.37M | 2.46M |
| EBITDA Margin % | 51.41% | 46.48% | 44.02% | 13.96% | -13.98% | 37.62% | 38.24% | 25.49% | 11.89% | 8.36% |
| EBITDA Growth % | 17.66% | -5.44% | -4.52% | -66.86% | -186.68% | 366.02% | 13.86% | -28.02% | -38.01% | -53.13% |
| D&A (Non-Cash Add-back) | 6.33M | 6.68M | 6.82M | 7.41M | 6.97M | 5.28M | 5.12M | 5.17M | 6.17M | 6.08M |
| EBIT | 4.99M | 4.34M | 3.49M | 2.86M | -8.4M | 1.69M | 3.32M | 1.81M | 2.74M | -2.27M |
| Net Interest Income | -1.69M | -1.92M | -1.43M | -1.3M | -1.05M | -742K | -719K | -686K | -1.25M | -1.54M |
| Interest Income | 15K | 3K | 198K | 16K | 10K | 0 | 87K | 426K | 248K | 145K |
| Interest Expense | 1.71M | 1.93M | 1.63M | 1.32M | 1.06M | 742K | 806K | 1.11M | 1.5M | 1.68M |
| Other Income/Expense | -93K | -576K | 220K | 16K | 10K | -404K | 87K | 426K | 4.04M | -332K |
| Pretax Income | 3.19M▲ 0% | 1.84M▼ 42.5% | 2.08M▲ 13.3% | 1.56M▼ 25.1% | -9.45M▼ 706.7% | 947K▲ 110.0% | 2.52M▲ 165.9% | 696K▼ 72.4% | 1.24M▲ 77.7% | -3.96M▲ 0% |
| Pretax Margin % | 17.07% | 9.39% | 10.56% | 7.56% | -53% | 5.37% | 12.75% | 3.26% | 4.36% | -13.45% |
| Income Tax | 943K | -1.1M | 451K | 128K | -1.74M | 269K | 963K | 431K | -295K | -347K |
| Effective Tax Rate % | 29.53% | -60.04% | 21.67% | 8.22% | 18.38% | 28.41% | 38.24% | 61.93% | -23.85% | 8.77% |
| Net Income | 930K▲ 0% | 1.92M▲ 106.8% | 1.02M▼ 46.8% | 659K▼ 35.6% | -7.06M▼ 1171.0% | 194K▲ 102.7% | 1.33M▲ 584.5% | 610K▼ 54.1% | 2.19M▲ 258.4% | -2.25M▲ 0% |
| Net Margin % | 4.97% | 9.83% | 5.19% | 3.2% | -39.57% | 1.1% | 6.73% | 2.86% | 7.71% | -7.65% |
| Net Income Growth % | 161.1% | 106.77% | -46.8% | -35.58% | -1171.02% | 102.75% | 584.54% | -54.07% | 258.36% | -157.27% |
| Net Income (Continuing) | 2.25M | 2.94M | 1.63M | 1.43M | -7.72M | 678K | 1.55M | 265K | 1.53M | -3.61M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.68M | 6.03M | 5.95M | 5.78M | 4.38M | 4.35M | 4M | 3.65M | 4.84M | 4.03M |
| EPS (Diluted) | 0.17▲ 0% | 0.33▲ 94.1% | 0.17▼ 48.5% | 0.24▲ 41.2% | -1.14▼ 575.0% | 0.03▲ 102.8% | 0.21▲ 556.3% | 0.10▼ 54.6% | 0.33▲ 245.9% | -0.34▲ 0% |
| EPS Growth % | 160.71% | 94.12% | -48.48% | 41.18% | -575% | 102.81% | 556.25% | -54.57% | 245.91% | -164.3% |
| EPS (Basic) | 0.17 | 0.33 | 0.18 | 0.24 | -1.14 | 0.03 | 0.21 | 0.10 | 0.34 | - |
| Diluted Shares Outstanding | 5.47M | 5.83M | 6.02M | 5.93M | 6.18M | 6.06M | 6.3M | 6.39M | 6.7M | 6.58M |
| Basic Shares Outstanding | 5.47M | 5.75M | 5.84M | 5.92M | 6.18M | 6.04M | 6.3M | 6.36M | 6.5M | 6.58M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
AMS Balance Sheet
American Shared Hospital Services (AMS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 8.39M | 8.89M | 9.95M | 10.74M | 10.85M | 15.09M | 18.72M | 20.46M | 26.26M | 20.59M |
| Cash & Short-Term Investments | 2.87M | 2.15M | 1.44M | 1.43M | 3.96M | 8.14M | 12.34M | 13.69M | 11.03M | 5.34M |
| Cash Only | 2.87M | 2.15M | 1.44M | 1.43M | 3.96M | 8.14M | 12.34M | 13.69M | 11.03M | 5.34M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.38M | 5.24M | 6.88M | 7.06M | 4.58M | 4.82M | 4.13M | 4.85M | 12.66M | 14.62M |
| Days Sales Outstanding | 85.39 | 97.71 | 127.34 | 125.11 | 93.62 | 99.88 | 76.31 | 82.96 | 163.09 | 154.16 |
| Inventory | 250K | 350K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 9.21 | 11.73 | - | - | - | - | - | - | - | - |
| Other Current Assets | 250K | 350K | 350K | 350K | 1.15M | 944K | 1.01M | 644K | 1.18M | 586K |
| Total Non-Current Assets | 52.21M | 49.28M | 47.56M | 43.04M | 32.8M | 30.34M | 25.23M | 27.71M | 33.94M | 39.04M |
| Property, Plant & Equipment | 51.33M | 48.49M | 46.69M | 42.59M | 31.32M | 28.93M | 23.8M | 25.92M | 32.16M | 37.34M |
| Fixed Asset Turnover | 0.36x | 0.40x | 0.42x | 0.48x | 0.57x | 0.61x | 0.83x | 0.82x | 0.88x | 0.81x |
| Goodwill | 0 | 0 | 0 | 0 | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
| Intangible Assets | 0 | 0 | 0 | 0 | 78K | 78K | 78K | 78K | 78K | 78K |
| Long-Term Investments | 579K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 300K | -2.91B | -2.96B | -2.51B | 137K | 73K | 87K | 443K | 437K | 1.58M |
| Total Assets | 60.6M▲ 0% | 58.18M▼ 4.0% | 57.5M▼ 1.2% | 53.78M▼ 6.5% | 43.65M▼ 18.8% | 45.43M▲ 4.1% | 43.96M▼ 3.2% | 48.16M▲ 9.6% | 60.2M▲ 25.0% | 59.63M▲ 0% |
| Asset Turnover | 0.31x | 0.34x | 0.34x | 0.38x | 0.41x | 0.39x | 0.45x | 0.44x | 0.47x | 0.48x |
| Asset Growth % | 11.98% | -4% | -1.16% | -6.47% | -18.83% | 4.07% | -3.24% | 9.57% | 24.99% | 49.93% |
| Total Current Liabilities | 8.68M | 9.01M | 9.47M | 8.21M | 12.38M | 5.89M | 5.17M | 10.78M | 10.4M | 17.17M |
| Accounts Payable | 319K | 359K | 435K | 557K | 683K | 318K | 230K | 315K | 1.56M | 1.11M |
| Days Payables Outstanding | 11.76 | 12.03 | 12.98 | 14.86 | 18.64 | 10.65 | 7.39 | 9.6 | 29.76 | 19.45 |
| Short-Term Debt | 2.21M | 2.46M | 2.12M | 1.53M | 1.16M | 2.42M | 1.76M | 6.54M | 4.16M | 11.68M |
| Deferred Revenue (Current) | 610M | 504M | 382M | 286M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | -285.87M | 1.68M | 1.18M | 1.09M | 1.41M | 2.57M | 3.79M |
| Current Ratio | 0.97x | 0.99x | 1.05x | 1.31x | 0.88x | 2.56x | 3.62x | 1.90x | 2.52x | 2.52x |
| Quick Ratio | 0.94x | 0.95x | 1.05x | 1.31x | 0.88x | 2.56x | 3.62x | 1.90x | 2.52x | 2.52x |
| Cash Conversion Cycle | 82.85 | 97.41 | - | - | - | - | - | - | - | 134.71 |
| Total Non-Current Liabilities | 24.74M | 19.28M | 16.98M | 13.76M | 7.62M | 15.3M | 13.16M | 11.1M | 19.77M | 13.86M |
| Long-Term Debt | 5.11M | 3.6M | 3.33M | 1.95M | 3.44M | 14.32M | 12.21M | 11.04M | 17.34M | 8.63M |
| Capital Lease Obligations | 14.85M | 12.27M | 10.31M | 9M | 3.56M | 359K | 59K | 0 | 1.5M | 13.11M |
| Deferred Tax Liabilities | 4.18M | 2.91M | 2.96M | 2.51M | 418K | 478K | 822K | 63K | 924K | 3.7M |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 33.42M | 28.29M | 26.45M | 21.97M | 20M | 21.19M | 18.33M | 21.88M | 30.17M | 31.03M |
| Total Debt | 27.04M | 23.14M | 20.17M | 16.47M | 14.4M | 17.47M | 14.31M | 17.64M | 23.23M | 24.62M |
| Net Debt | 24.16M | 20.99M | 18.72M | 14.69M | 10.44M | 9.33M | 1.98M | 3.95M | 12.2M | 19.27M |
| Debt / Equity | 0.82x | 0.64x | 0.55x | 0.44x | 0.61x | 0.72x | 0.56x | 0.67x | 0.77x | 0.77x |
| Debt / EBITDA | 2.81x | 2.55x | 2.32x | 5.73x | - | 2.63x | 1.90x | 3.25x | 6.89x | 10.01x |
| Net Debt / EBITDA | 2.51x | 2.31x | 2.16x | 5.11x | - | 1.41x | 0.26x | 0.73x | 3.62x | 3.62x |
| Interest Coverage | 1.93x | 1.25x | 1.14x | -3.44x | -8.95x | 1.82x | 3.02x | 0.24x | -1.87x | -1.35x |
| Total Equity | 32.85M▲ 0% | 35.91M▲ 9.3% | 36.99M▲ 3.0% | 37.59M▲ 1.6% | 23.65M▼ 37.1% | 24.24M▲ 2.5% | 25.63M▲ 5.7% | 26.28M▲ 2.6% | 30.03M▲ 14.3% | 28.6M▲ 0% |
| Equity Growth % | 8.67% | 9.32% | 3.01% | 1.61% | -37.08% | 2.49% | 5.72% | 2.55% | 14.26% | 4% |
| Book Value per Share | 6.01 | 6.16 | 6.15 | 6.34 | 3.83 | 4.00 | 4.07 | 4.11 | 4.48 | 4.35 |
| Total Shareholders' Equity | 27.17M | 29.89M | 31.05M | 31.81M | 19.27M | 19.89M | 21.63M | 22.62M | 25.18M | 24.57M |
| Common Stock | 10.6M | 10.71M | 10.71M | 10.75M | 10.75M | 10.76M | 10.76M | 10.76M | 10.76M | 10.76M |
| Retained Earnings | 4.95M | 6.87M | 7.9M | 8.55M | 1.5M | 1.69M | 3.02M | 3.63M | 5.82M | 4.89M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -53.55M | -51.67M | -54.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.68M | 6.03M | 5.95M | 5.78M | 4.38M | 4.35M | 4M | 3.65M | 4.84M | 4.03M |
AMS Cash Flow Statement
American Shared Hospital Services (AMS) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 8.38M | 7.85M | 8.06M | 8.05M | 9.74M | 6.27M | 7.24M | 5.72M | 167K | 167K |
| Operating CF Margin % | 44.8% | 40.16% | 40.89% | 39.05% | 54.63% | 35.55% | 36.64% | 26.81% | 0.59% | - |
| Operating CF Growth % | -1.99% | -6.27% | 2.66% | -0.19% | 21.1% | -35.69% | 15.45% | -20.97% | -97.08% | 468.29% |
| Net Income | 2.25M | 2.94M | 1.63M | 1.43M | -7.72M | 194K | 1.55M | 265K | 1.53M | -2.25M |
| Depreciation & Amortization | 6.33M | 6.68M | 6.82M | 7.41M | 6.97M | 5.28M | 4.78M | 5.17M | 6.17M | 6.08M |
| Stock-Based Compensation | 215K | 323K | 223K | 230K | 299K | 0 | 399K | 389K | 373K | 291K |
| Deferred Taxes | 772K | -1.27M | 48K | -444K | -2.16M | 60K | 344K | -759K | -359K | -542K |
| Other Non-Cash Items | 526K | 707K | 39K | 361K | 8.54M | 1.58M | 450K | 952K | -607K | 2.72M |
| Working Capital Changes | -1.71M | -1.53M | -696K | -941K | 3.82M | -853K | -296K | -294K | -6.95M | -1.46M |
| Change in Receivables | -1.23M | -860K | -420K | -1.19M | 2.97M | -519K | 696K | -719K | -6.94B | -4.92M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -199M | 125M | 115K | 28K | 263K | 851K | 608K | -79K | 2.23B | -1.2M |
| Cash from Investing | -1.61M | -653K | -1.53M | -990K | -2.39M | -1.67M | -388K | -6.27M | -7.11M | -13.98M |
| Capital Expenditures | -1.61M | -803K | -1.58M | -990K | -455K | -1.67M | -388K | -6.27M | -7.94M | -14.28M |
| CapEx % of Revenue | 8.62% | 4.11% | 8% | 4.8% | 2.55% | 9.5% | 1.97% | 29.42% | 28.01% | - |
| Acquisitions | 7K | 150K | 0 | 0 | -2.08M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 150K | 51K | 0 | 150K | 0 | 0 | 0 | 833K | 295K |
| Cash from Financing | -6.1M | -7.92M | -7.25M | -7.07M | -4.81M | -655K | -2.66M | 1.91M | 4.41M | 1.18M |
| Debt Issued (Net) | -6M | -7.27M | -6.56M | -6.17M | -4.05M | 255K | -2.03M | 2.12M | 4.63M | 1.25M |
| Equity Issued (Net) | 220K | 0 | 0 | 0 | 0 | 5K | 5K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -692K | -551K | -690K | -897K | -761K | -915K | -630K | -211K | -221K | -80K |
| Net Change in Cash | 662K▲ 0% | -719K▼ 208.6% | -710K▲ 1.3% | -13K▲ 98.2% | 2.55M▲ 19684.6% | 3.94M▲ 54.7% | 4.19M▲ 6.4% | 1.35M▼ 67.7% | -2.53M▼ 286.9% | -8.73M▲ 0% |
| Free Cash Flow | 6.77M▲ 0% | 7.05M▲ 4.2% | 6.49M▼ 8.0% | 7.06M▲ 8.8% | 9.29M▲ 31.6% | 4.59M▼ 50.6% | 6.85M▲ 49.1% | -555K▼ 108.1% | -7.77M▼ 1300.2% | -10.2M▲ 0% |
| FCF Margin % | 36.18% | 36.05% | 32.9% | 34.25% | 52.08% | 26.06% | 34.68% | -2.6% | -27.42% | -34.67% |
| FCF Growth % | 2.02% | 4.2% | -8.01% | 8.82% | 31.64% | -50.56% | 49.07% | -108.11% | -1300.18% | -55.95% |
| FCF per Share | 1.24 | 1.21 | 1.08 | 1.19 | 1.50 | 0.76 | 1.09 | -0.09 | -1.16 | -1.16 |
| FCF Conversion (FCF/Net Income) | 9.01x | 4.08x | 7.88x | 12.21x | -1.38x | 32.30x | 5.45x | 9.37x | 0.08x | 4.53x |
| Interest Paid | 2.15M | 1.57M | 1.61M | 1.32M | 938K | 0 | 722K | 1.07M | 1.4M | 1.19M |
| Taxes Paid | 266K | 126K | 459K | 397K | 339K | 0 | 169K | 297K | 1.85M | 434K |
AMS Key Ratios
American Shared Hospital Services (AMS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 2.95% | 5.59% | 2.81% | 1.77% | -23.05% | 0.81% | 5.33% | 2.35% | 7.76% | -7.87% |
| Return on Invested Capital (ROIC) | 4.56% | 3.18% | 2.48% | -6.28% | -16.37% | 3% | 5.96% | 0.7% | -5.81% | -5.81% |
| Gross Margin | 47.03% | 44.3% | 37.97% | 33.58% | 25.04% | 38.16% | 42.45% | 43.82% | 32.41% | 24.98% |
| Net Margin | 4.97% | 9.83% | 5.19% | 3.2% | -39.57% | 1.1% | 6.73% | 2.86% | 7.71% | -7.65% |
| Debt / Equity | 0.82x | 0.64x | 0.55x | 0.44x | 0.61x | 0.72x | 0.56x | 0.67x | 0.77x | 0.77x |
| Interest Coverage | 1.93x | 1.25x | 1.14x | -3.44x | -8.95x | 1.82x | 3.02x | 0.24x | -1.87x | -1.35x |
| FCF Conversion | 9.01x | 4.08x | 7.88x | 12.21x | -1.38x | 32.30x | 5.45x | 9.37x | 0.08x | 4.53x |
| Revenue Growth | 13% | 4.58% | 0.81% | 4.52% | -13.43% | -1.17% | 12.02% | 8% | 32.9% | 17.84% |
AMS Frequently Asked Questions
American Shared Hospital Services (AMS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
American Shared Hospital Services (AMS) reported $29.4M in revenue for fiscal year 2024. This represents a 14% decrease from $34.1M in 1995.
American Shared Hospital Services (AMS) grew revenue by 32.9% over the past year. This is strong growth.
American Shared Hospital Services (AMS) reported a net loss of $2.3M for fiscal year 2024.
Dividend & Returns
American Shared Hospital Services (AMS) has a return on equity (ROE) of 7.8%. This is below average, suggesting room for improvement.
American Shared Hospital Services (AMS) had negative free cash flow of $10.2M in fiscal year 2024, likely due to heavy capital investments.
Explore More AMS
American Shared Hospital Services (AMS) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates